Get an alert when MSD ANIMAL HEALTH UK LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-05-27 (this month)

Last made up 2025-05-13

Watchouts

None on the register

Cash

£4K

Latest balance sheet

Net assets

£159M

-4.4% vs 2023

Employees

252

-2.7% vs 2023

Profit before tax

£8M

+3.6% vs 2023

Name history

Renamed 2 times since incorporation

  1. MSD ANIMAL HEALTH UK LIMITED 2020-03-27 → present
  2. INTERVET UK LIMITED 1987-04-15 → 2020-03-27
  3. INTERVET LABORATORIES LIMITED 1969-01-29 → 1987-04-15

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £185,890,000£198,456,000
Operating profit £3,944,000£4,798,000
Profit before tax £7,330,000£7,596,000
Net profit £3,459,000£4,410,000
Cash £4,000
Total assets less current liabilities £183,209,000£177,848,000
Net assets £166,795,000£159,459,000
Equity £166,795,000£159,459,000
Average employees 259252
Wages £17,194,000£17,823,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin 2.1%2.4%
Net margin 1.9%2.2%
Return on capital employed 2.2%2.7%
Current ratio 1.44x1.28x
Interest cover 4.95x7.69x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
PricewaterhouseCoopers LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Given the matters described above, the Directors believe that the Company has the resources required to settle all liabilities via the group cash pooling arrangement as they fall due for at least 12 months from the date of signing the financial statements and that no material uncertainties exist. Accordingly, the financial statements have been prepared on a going concern basis. The directors remain confident on the basis of the future projections that they have adequate resources to continue in operation for the foreseeable future.”

Group structure

  1. MSD ANIMAL HEALTH UK LIMITED · parent
    1. Intervet UK Production Limited 100% · England, UK · Production and sale of veterinary products
    2. MSD Pensions Trustee Limited 100% · England, UK · Dormant

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 28 resigned

Name Role Appointed Born Nationality
CAN TEMUCIN, Ebru Director 2018-07-05 Oct 1972 Turkish
CASAGRANDE, Henrique Augusto Director 2026-01-31 Mar 1977 Brazilian,American
LITVIN, Dionna Kathleen Director 2023-10-31 Aug 1970 American
Show 28 resigned officers
Name Role Appointed Resigned
BOUW, Andreas Johannes Louis Maria Secretary 2005-04-18 2007-03-16
BURWOOD, Alan Edward Secretary 2005-04-18
PLAYFORD, Richard Secretary 2007-03-16 2008-12-05
VAN HEUMEN, Marcus Secretary 2008-12-05 2013-01-31
BATTISON, John Robert Director 1995-07-03 2002-04-01
BAXENDALE, William Director 2004-03-31
BOLCSKEI, Andras Director 2012-09-25 2015-10-01
CASADY, Paul Stoughton Director 2002-04-01 2005-12-01
COSTA, Andrea Frances Director 2014-12-11 2018-07-05
EHREN, Stijn Michiel Director 2008-12-05 2011-12-13
HALLAS, David Charles Director 2008-12-05 2012-09-25
HARBERG JR., Allen Director 2013-01-31 2019-06-03
HILADO, Maria Teresa Director 2008-12-05 2009-07-02
KALFF, Tjeerd Director 1994-04-30
KOEHLER, Steven Hubrig Director 2008-12-05 2011-07-22
LANZ CANDURIN, Helene Tatiana Director 2024-08-01 2026-01-31
MCCOY JR., Barry Lee Director 2019-06-03 2023-10-31
MCDOWELL, Mark Andrew Charles Director 2011-12-13 2012-05-25
MEISLOCH, Karsten Clemens Director 2012-06-01 2014-12-11
MOEHLENBROCK, Jan Director 2017-01-24 2024-08-01
PRECIOUS, John Frederick Director 1995-07-03
STOLP, Ruurd Director 2002-05-31 2008-12-15
STOLP, Ruurd Director 2002-05-31 2002-05-31
VAN DOMMELEN, Bernadus Henricus Maria Director 1994-04-30
VARVELLA VICENTE, Mauricio Director 2015-10-01 2017-01-24
WETTERHAHN, Pieter Paulus Director 2005-12-01 2008-06-12
WIEDHAUP, Koenraad Director 1994-05-01 2000-06-15
WILDERBEEK, Antonius Theodorus Maria Director 1994-05-01 2002-05-31

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Merck & Co., Inc. Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 211 total filings

Date Type Category Description
2026-04-07 AP01 officers Appoint person director company with name date PDF
2026-02-09 TM01 officers Termination director company with name termination date PDF
2025-12-05 AA accounts Accounts with accounts type full
2025-09-05 AAMD accounts Accounts amended with accounts type full
2025-05-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-09-30 AA accounts Accounts with accounts type full
2024-09-10 AP01 officers Appoint person director company with name date PDF
2024-08-12 TM01 officers Termination director company with name termination date PDF
2024-05-13 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-11-07 AP01 officers Appoint person director company with name date PDF
2023-11-03 TM01 officers Termination director company with name termination date PDF
2023-10-30 AA accounts Accounts with accounts type full
2023-05-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-10-01 AA accounts Accounts with accounts type full
2022-06-09 PSC05 persons-with-significant-control Change to a person with significant control PDF
2022-05-16 CS01 confirmation-statement Confirmation statement with updates PDF
2022-01-26 AA accounts Accounts with accounts type full
2022-01-17 SH01 capital Capital allotment shares
2021-05-27 CS01 confirmation-statement Confirmation statement with updates PDF
2021-01-28 SH01 capital Capital allotment shares

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
5

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page